Literature DB >> 10768987

Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection.

D L Narum1, S A Ogun, A W Thomas, A A Holder.   

Abstract

We have purified apical merozoite antigen 1 (AMA-1) from extracts of red blood cells infected with the rodent malaria parasite Plasmodium yoelii yoelii YM. When used to immunize mice, the protein induced a strong protective response against a challenge with the parasite. Monoclonal antibodies specific for P. yoelii yoelii AMA-1 were prepared, and one was very effective against the parasite on passive immunization. A second protein that appears to be located in the apical rhoptry organelles and associated with AMA-1 was identified.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10768987      PMCID： PMC97502          DOI： 10.1128/IAI.68.5.2899-2906.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  44 in total

1.  The 42-kilodalton rhoptry-associated protein of Plasmodium falciparum.

Authors:  A Saul; J Cooper; D Hauquitz; D Irving; Q Cheng; A Stowers; T Limpaiboon
Journal:  Mol Biochem Parasitol       Date:  1992-01       Impact factor: 1.759

2.  Analysis of variation in PF83, an erythrocytic merozoite vaccine candidate antigen of Plasmodium falciparum.

Authors:  A W Thomas; A P Waters; D Carr
Journal:  Mol Biochem Parasitol       Date:  1990 Sep-Oct       Impact factor: 1.759

3.  Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile.

Authors:  W E Collins; D Pye; P E Crewther; K L Vandenberg; G G Galland; A J Sulzer; D J Kemp; S J Edwards; R L Coppel; J S Sullivan
Journal:  Am J Trop Med Hyg       Date:  1994-12       Impact factor: 2.345

4.  Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites.

Authors:  D L Narum; A W Thomas
Journal:  Mol Biochem Parasitol       Date:  1994-09       Impact factor: 1.759

5.  Sequence analysis of the apical membrane antigen I (AMA-1) of Plasmodium vivax.

Authors:  Q Cheng; A Saul
Journal:  Mol Biochem Parasitol       Date:  1994-05       Impact factor: 1.759

6.  Ion-exchange-immunoaffinity purification of a recombinant baculovirus Plasmodium falciparum apical membrane antigen, PF83/AMA-1.

Authors:  D L Narum; G W Welling; A W Thomas
Journal:  J Chromatogr A       Date:  1993-12-31       Impact factor: 4.759

7.  Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum.

Authors:  H M Etlinger; P Caspers; H Matile; H J Schoenfeld; D Stueber; B Takacs
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

8.  High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1.

Authors:  A W Thomas; J F Trape; C Rogier; A Goncalves; V E Rosario; D L Narum
Journal:  Am J Trop Med Hyg       Date:  1994-12       Impact factor: 2.345

9.  Immunization against malaria with a recombinant protein.

Authors:  I T Ling; S A Ogun; A A Holder
Journal:  Parasite Immunol       Date:  1994-02       Impact factor: 2.280

10.  Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.

Authors:  M J Blackman; T J Scott-Finnigan; S Shai; A A Holder
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307
View more
  47 in total

1.  Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1.

Authors:  Alfred Cortés; Mata Mellombo; Ivo Mueller; Ariadna Benet; John C Reeder; Robin F Anders
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

2.  Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1.

Authors:  Markus S Mueller; Annabelle Renard; Francesca Boato; Denise Vogel; Martin Naegeli; Rinaldo Zurbriggen; John A Robinson; Gerd Pluschke
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

3.  Production of the subdomains of the Plasmodium falciparum apical membrane antigen 1 ectodomain and analysis of the immune response.

Authors:  P V Lalitha; Lisa A Ware; Arnoldo Barbosa; Sheetij Dutta; J Kathleen Moch; J David Haynes; Bader B Fileta; Charles E White; David E Lanar
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

4.  Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.

Authors:  Alfred Cortés; Mata Mellombo; Rosella Masciantonio; Vince J Murphy; John C Reeder; Robin F Anders
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  Binding hot spot for invasion inhibitory molecules on Plasmodium falciparum apical membrane antigen 1.

Authors:  Karen S Harris; Joanne L Casey; Andrew M Coley; Rosella Masciantonio; Jennifer K Sabo; David W Keizer; Erinna F Lee; Andrew McMahon; Raymond S Norton; Robin F Anders; Michael Foley
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  Mimotopes of apical membrane antigen 1: Structures of phage-derived peptides recognized by the inhibitory monoclonal antibody 4G2dc1 and design of a more active analogue.

Authors:  Jennifer K Sabo; David W Keizer; Zhi-Ping Feng; Joanne L Casey; Kathy Parisi; Andrew M Coley; Michael Foley; Raymond S Norton
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

7.  Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria.

Authors:  Prakash Srinivasan; Emmanuel Ekanem; Ababacar Diouf; Michelle L Tonkin; Kazutoyo Miura; Martin J Boulanger; Carole A Long; David L Narum; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

8.  Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells.

Authors:  G H Mitchell; A W Thomas; G Margos; A R Dluzewski; L H Bannister
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Plasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.

Authors:  Shigeto Yoshida; Hiroshi Nagumo; Takashi Yokomine; Hitomi Araki; Ayaka Suzuki; Hiroyuki Matsuoka
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

10.  Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity.

Authors:  Kwadwo A Kusi; Bart W Faber; Alan W Thomas; Edmond J Remarque
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.